Your Messages Inbox
Your Article Summary
See Latest ArticlesGenzyme Provides Update on Allston Landing Plant
Genzyme, 08/03/09
Genzyme Corporation announced that the FDA informed the company late Thursday that it will re–inspect the company's Allston Landing manufacturing facility. The re–inspection is a follow–up to an inspection the agency conducted in May 2009 and is intended to verify that all corrective and preventative actions identified in a February warning letter have been implemented.
Today in Regulatory Issues...keeping you current
Receive free subspecialty "5-minute updates" via email
Mandatory Disclosure of Pharmaceutical Industry-Funded Events for Health Professionals
PLoS Medicine, 12/02/09
FDA drug approval intervals from 1997 to 2006: analysis and comparison during information technology implementation
International Journal of Electronic Healthcare , 12/01/09
Regulatory Update: GSK files Rotarix for prevention of rotavirus in Japan
GlaxoSmithKline, 12/01/09
Article Search
Sponsor